Here the plasma and CSF proteome were assessed using the SomaScan assay for 11,270 APOE ε4 carriers and noncarriers with AD, FTD, PD, PDD, ALS and nonimpaired controls. This evidence concerns the gene APOE and frontotemporal dementia.